Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Fortress Biotech Inc. logo

Fortress Biotech Inc.

Sector: Healthcare   

Industry: Biotechnology

2.43
 
USD
  
0.35
  
(16.83%)
Optionable: Yes  Market Cap: 18 M  90-day average vol: 575,179

Previous close: 2.08  Open: 2.12  Bid: 2.32  Ask: 2.43
52 week range    
1.24   
   12.75
Peers   
VCYT / 
EBS / 
ADXS / 
Last updated: Monday 4th March 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

FBIO Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends-299000.0-2 M-3 M-7 M-8 M-8 M
Amortization of intangibles-509000.0-2 M-1 M-1 M
Basic EPS from continuing operations-3.95-4.95-2.59-0.79
Basic EPS total-1.21-1.48-4.01-5.21-3.72-0.79-0.97
Basic weighted shares outstanding30 M36 M39 M40 M42 M43 M55 M72 M82 M89 M
BasicDiscontinuousOperations-0.06-0.26-1.13
CommissionExpenses10 M
Cost of sales-141000.0-24000.0-790000.04 M6 M11 M15 M42 M-31 M
Depreciation-17000.0-23000.0-26000.0-400000.0-726000.0-1 M-2 M-2 M-3 M-3 M
Depreciation unreconciled545000.0
DepreciationAndAmortization-17000.0-23000.0-26000.0-400000.0-726000.0-1 M-2 M-2 M-3 M-3 M
DevelopmentExpense75 M3 M16 M700000.0
Diluted EPS total-1.22-0.56-1.24-1.38-4.01-5.21-3.72-1.43-0.79-0.97
Diluted normalized net income/share-0.65-0.79
Diluted weighted shares outstanding30 M36 M8 M130 M42 M43 M55 M72 M82 M89 M
DilutedDiscontinuousOperations-0.78-1.23
Fees7 M104.0
GainOnSaleOfPPE18 M
GainOnSaleOfSecurity2 M18 M
GainsLossOnDisposalOfDiscontinuedOperations-2 M-13 M
GeneralAndAdministrativeExpense10 M10 M-19 M28 M51 M53 M56 M-44 M-2 M-2 M
Gross operating profit141000.03 M32 M14 M-3 M-9 M-14 M-36 M-29 M
ImpairmentOfCapitalAssets-400000.0
Income before tax-37 M-20 M-54 M-71 M-98 M-131 M-102 M-103 M-164 M-213 M
Income restructuring and M&A-136000.0-154000.0-200000.0
Income taxes-67 M-2 M-10 M-12 M136000.0473000.0449000.0
Interest income545000.0266000.0-3 M-76 M819000.01 M3 M-7 M25 M-11 M
InterestExpenseNonOperating2 M-1 M-1 M-4 M-7687.0-10340.0-12 M-15 M-15 M-12 M
InterestExpenseOperating-2 M-9 M-10 M-11 M-10 M
MinorityInterests5 M16 M33 M58 M62 M56 M100 M127 M
MiscOtherSpecialCharges942000.0-438000.0-1 M-9 M11 M23 M43 M63 M75 M
Net income from total operations-37 M-20 M-10 M-180 M-67 M-84 M-40 M-46 M-65 M-87 M
NetIncomeCommonStockholders-37 M-20 M-10 M-180 M-67 M-84 M-40 M-46 M-65 M-87 M
NetIncomeContinuousOperations-37 M-20 M-10 M-180 M-67 M-84 M-40 M-46 M-65 M-87 M
NetIncomeDiscontinuousOperations-2 M-11 M
NetIncomeFromOtherGainsLosses942000.0
NetNonOperatingInterestIncomeExpense-1 M266000.0-3 M-76 M819000.01 M3 M-7 M25 M-11 M
NonRecurringOperationExpense1000.0
Operating income-36 M-21 M-12 M-119 M-90 M-143 M-146 M-139 M-252 M-277 M
Operating income before depreciation (EBITDA)-37 M-22 M-55 M-72 M-93 M-126 M-114 M-117 M-180 M-225 M
OperatingExpense-36 M-21 M-51 M-82 M103 M141 M137 M125 M216 M249 M
Other income net-373000.0-942000.0438000.01 M9 M-11 M-42 M-43 M-63 M-75 M
Other special charges-17 M-16 M
OtherGainLossFromDispositionOfDiscontinuedOperations-810000.02 M
OtherGandA10 M10 M-19 M28 M51 M53 M56 M-44 M-2 M-2 M
OtherImpairmentOfCapitalAssets-373000.0-250000.0
OtherOperatingExpenses51 M82 M-107 M-6 M-3 M-3 M-3 M-4 M
OtherTaxes-400000.0
OtherunderPreferredStockDividend-299000.0-2 M-3 M-7 M-8 M-8 M
PreferredStockDividends-299000.0-2 M-3 M-7 M-8 M-8 M
RentAndLandingFees10 M10 M-19 M28 M-1 M-2 M-2 M
Research & development expense26 M10 M-18 M41 M52 M87 M81 M64 M129 M135 M
ResearchExpense26 M10 M-18 M41 M52 M87 M6 M61 M113 M134 M
RestructringAndMnAIncome-136000.0-154000.0-200000.0
Revenue per share-20000.0-4 M-314000.0-692000.0-3141.0-2 M-4 M-7 M-4 M-2 M
SalariesAndWages-6 M-6 M-14 M-12 M-13 M-15 M-13 M-13 M-19 M-23 M
Selling Gen & administrative expense10 M10 M-19 M28 M51 M53 M56 M61 M87 M114 M
SellingAndMarketingExpense-3 M-6 M-10 M-12 M-17 M61 M87 M114 M
SellingExpense61 M87 M114 M
Special income/charges136000.0400000.0200000.017 M17 M
Total Income available for interest expense (EBIT)-37 M-22 M-55 M-75 M-98 M-131 M-122 M-128 M-191 M-236 M
Total common shares outstanding44 M46 M49 M50 M51 M61 M78 M98 M108 M133 M
Total net income-37 M-20 M-10 M-180 M-67 M-84 M-40 M-46 M-65 M-87 M
Total ordinary shares9 M9 M9 M9 M9 M9 M9 M9 M9 M9 M
Total revenues3 M33 M17 M4 M2 M1 M6 M2 M
TotalExpenses-36 M-21 M-51 M-83 M107 M147 M147 M140 M257 M218 M
TotalRevenue863000.016 M17 M4 M2 M1 M6 M76 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University